I am a
Home I AM A Search Login

Papers of the Week

2021 Dec 31

Saudi Pharm J

Analyzing the U.S. Post-marketing safety surveillance of COVID-19 vaccines.


Albalawi OM, Alomran MI, Alsagri GM, Althunian TA, Alshammari TM
Saudi Pharm J. 2021 Dec 31.
PMID: 35002372.


Since December 2020, three COVID-19 vaccines have been authorized in the United States (U.S.) and were proceeded by large immunization programs. The aim of this study was to characterize the U.S. post-marketing safety (PMS) profiles of these vaccines with an in-depth analysis of mortality data.